generated CCL19-IL-7 CAR-Ts and reported that these cells mediated effective tumoricidal responses in mouse models of solid tumors with enhanced tumor-site trafficking and expansion even in the immunosuppressive TME (155). This evidence concerns the gene CCL19 and neoplasm.